Published in Anal Biochem on October 01, 1989
Isoelectric focusing technology quantifies protein signaling in 25 cells. Proc Natl Acad Sci U S A (2006) 1.89
Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency. N Engl J Med (1977) 2.12
Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res (1992) 2.00
Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. J Clin Invest (1978) 1.61
Redox regulation of signal transduction: tyrosine phosphorylation and calcium influx. Proc Natl Acad Sci U S A (1994) 1.55
Purification and properties of glutathione reductase of human erythrocytes. Biochim Biophys Acta (1969) 1.31
Human erythrocyte pyruvate kinase. Its purification and some properties. Biochim Biophys Acta (1971) 1.25
Characterization of alpha-L-fucosidase from two different families with fucosidosis. Clin Chim Acta (1976) 1.20
An abnormal form of purine nucleoside phosphorylase in a family with a child with severe defective T-cell-and normal B-cell immunity. Clin Chim Acta (1976) 1.03
Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. Cancer Res (1989) 1.01
Pyruvate kinase activity and isozyme composition in normal fibrous tissue and fibroblastic proliferations. Cancer (1991) 1.00
Purification and some properties of human erythrocyte hexokinase. Biochim Biophys Acta (1976) 0.99
The reaction mechanism of glutathione reductase from human erythrocytes. Biochim Biophys Acta (1969) 0.97
Glycolytic enzyme activities in breast cancer metastases. Tumour Biol (1988) 0.96
Isoenzymes of phosphofructokinase in the rat. Demonstration of the three non-identical subunits by biochemical, immunochemical and kinetic studies. Biochem J (1985) 0.96
Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes. J Clin Invest (1980) 0.93
Regulation of human erythrocyte hexokinase. The influence of glycolytic intermediates and inorganic phosphate. Biochim Biophys Acta (1977) 0.92
Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue. Tumour Biol (1987) 0.91
Subunit composition, regulatory properties, and phosphorylation of phosphofructokinase from human gliomas. Cancer Res (1987) 0.91
Partial hypoxanthine-guanine phosphoribosyl transferase deficiency with full expression of the Lesch-Nyhan syndrome. Hum Genet (1981) 0.91
Characterization of mutant subunits of human purine nucleoside phosphorylase. J Biol Chem (1978) 0.89
The effect of deoxyguanosine on human lymphocyte function. I. Analysis of the interference with lymphocyte proliferation in vitro. J Immunol (1984) 0.89
Generalized hexokinase deficiency in the blood cells of a patient with nonspherocytic hemolytic anemia. Blood (1983) 0.88
Orotic aciduria in two unrelated patients with inherited deficiencies of purine nucleoside phosphorylase. J Clin Invest (1977) 0.88
Compartmentation of hexokinase in human blood cells. Characterization of soluble and particulate enzymes. Biochim Biophys Acta (1982) 0.87
Isozyme pattern of enolase of childhood tumors. Cancer (1984) 0.87
The influence of glucose I,6-diphosphate on the enzymatic activity of pyruvate kinase. Biochim Biophys Acta (1972) 0.87
Alanine inhibition of pyruvate kinase in gliomas and meningiomas. A diagnostic tool in surgery for gliomas? Lancet (1977) 0.86
Characteristics of hexokinase, pyruvate kinase, and glucose-6-phosphate dehydrogenase during adult and neonatal reticulocyte maturation. Am J Hematol (1985) 0.86
Standardization of an enzyme-linked immunosorbent assay for the determination of protein tyrosine kinase activity. Anal Biochem (1993) 0.86
Isozymes of pyruvate kinase from human brain, meningiomas, and malignant gliomas. Cancer Res (1978) 0.85
Purification and properties of an abnormal glutathione reductase from human erythrocytes. Biochim Biophys Acta (1969) 0.85
Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes. Adv Exp Med Biol (1986) 0.84
Cyclin D3 regulates proliferation and apoptosis of leukemic T cell lines. J Biol Chem (1999) 0.84
Alkyllysophospholipid ET-18-OCH3 acts as an activator of protein kinase C in HL-60 cells. FEBS Lett (1991) 0.83
Characterization of some glycolytic enzymes from human retina and retinoblastoma. Cancer Res (1982) 0.83
A patient with purine nucleoside phosphorylase deficiency: enzymological and metabolic aspects. Clin Chim Acta (1977) 0.82
Separation and characterization of hexokinase I subtypes from human erythrocytes. Biochim Biophys Acta (1981) 0.82
Mitochondrial and cytosolic hexokinase from rat brain: one and the same enzyme? Biochim Biophys Acta (1983) 0.82
Heterogeneity of glycolytic enzyme activity and isozyme composition of pyruvate kinase in breast cancer. Tumour Biol (1988) 0.81
An approach to the restoration of T cell function in a purine nucleoside phosphorylase deficient patient. Ciba Found Symp (1978) 0.81
Isozymic composition and regulatory properties of phosphofructokinase from well-differentiated and anaplastic medullary thyroid carcinomas of the rat. Cancer Res (1985) 0.81
Regulation of human erythrocyte hexokinase by glucose-1, 6-diphosphate and inorganic phosphate. FEBS Lett (1977) 0.81
The pyruvate kinase isoenzyme shift in human gliomas: a potential marker in the treatment of gliomas. Br J Neurosurg (1988) 0.80
Glycolytic enzymes of an erythroleukemic cell line, K562, before and after hemoglobin induction. Exp Hematol (1983) 0.80
Some properties of abnormal red blood cell pyruvate kinase. Biochim Biophys Acta (1970) 0.80
Glycolytic enzymes from human neuroectodermal tumors of childhood. Eur J Cancer Clin Oncol (1984) 0.80
Lysosomal enzymes in normal and leukemic B lymphocytes. Clin Chim Acta (1982) 0.80
Alterations in size, shape and osmotic behaviour of red cells after splenectomy: a study of their age dependence. Br J Haematol (1988) 0.80
Nonradioactive assays of protein-tyrosine kinase activity using anti-phosphotyrosine antibodies. Methods Enzymol (1991) 0.79
Properties of glutathione reductase purified from erythrocytes with normal and with diminished activity of the enzyme. Ned Tijdschr Geneeskd (1968) 0.79
Correlation between alanine inhibition of pyruvate and composition of K-M hybrids. Clin Chim Acta (1981) 0.79
Phosphorylation of pyruvate kinase and glycolytic metabolism in three human glioma cell lines. Tumour Biol (1991) 0.79
L-alpha-alanine inhibition of pyruvate kinase from tumors of the human central nervous system. Cancer Res (1979) 0.79
Changes in activities and isozyme patterns of glycolytic enzymes during erythroid differentiation in vitro. Blood (1984) 0.79
Reticulocyte crisis after splenectomy: evidence for delayed red cell maturation? Eur J Haematol (1988) 0.79
Extreme deficiency of L-type pyruvate kinase with moderate clinical expression. Clin Chim Acta (1982) 0.79
Determination and characterization of hexokinase in thyroid cancer and benign neoplasms. Cancer (1985) 0.79
Enolase isozymes in differentiated and undifferentiated medullary thyroid carcinomas. Cancer (1985) 0.78
How did retinoblastoma arise? Nature (1984) 0.78
Properties of human erythrocyte hexokinase related to cell age. Clin Chim Acta (1977) 0.78
Enolase isoenzymes in human gliomas. J Neurosurg (1986) 0.78
Isozyme distribution of hexokinase, phosphofructokinase and pyruvate kinase in lymphocytes from patients with chronic lymphocytic leukemia. Clin Chim Acta (1982) 0.78
A new variant of glucosephosphate isomerase deficiency: GPI-Kortrijk. Clin Chim Acta (1977) 0.78
Pyruvate kinase in human brain tumours. Its significance in the treatment of gliomas. Acta Neurochir (Wien) (1982) 0.78
Human erythrocyte pyruvate kinase deficiency: the use of a kinetic study of mutant enzymes for the detection of heterozygotes. Hum Genet (1978) 0.78
Glycolytic activity in human red cell populations separated by a combination of density and counterflow centrifugation. Evidence for an improved separation of red cells according to age. Scand J Haematol (1986) 0.78
Human erythrocyte phosphofructokinase: its purification and some properties. Biochim Biophys Acta (1972) 0.78
Erythrocyte Na+/K+ ATPase activity measured with 23Na NMR. Magn Reson Med (1989) 0.78
Some properties of pyruvate kinase of human erythrocytes. Bull Soc Chim Biol (Paris) (1970) 0.78
Phosphorylation of pyruvate kinase type K is restricted to the dimeric form. Biochim Biophys Acta (1992) 0.78
The effect of a varying Mg2+ free concentration upon the kinetic behaviour of human liver L-type pyruvate kinase. FEBS Lett (1979) 0.78
Pyruvate kinase and the "high ATP syndrome". J Clin Invest (1984) 0.77
An enzyme-linked immunosorbent assay for the determination of src-family tyrosine kinase activity in breast cancer. Breast Cancer Res Treat (1996) 0.77
Functional interaction between the epidermal growth factor receptor and c-Src kinase activity. FEBS Lett (1994) 0.77
Protein kinase C is not involved in the cytotoxic action of 1-octadecyl-2-O-methyl-sn-glycerol-3-phosphocholine in HL-60 and K562 cells. Biochem Pharmacol (1994) 0.77
Activity of glycolytic enzymes and glucose-6-phosphate dehydrogenase in smooth muscle proliferation. Tumour Biol (1990) 0.77
Counterflow centrifugation of red cell populations: a cell age related separation technique. Br J Haematol (1985) 0.77
Influence of Mg2. Biochim Biophys Acta (1974) 0.77
A new variant of glucosephosphate isomerase deficiency. Humangenetik (1975) 0.77
Human platelet 6-phosphofructokinase. Purification, kinetic parameters and the influence of sulphate ions on enzyme activity. Biochim Biophys Acta (1974) 0.77
The effect of urea and temperature on red blood cell pyruvate kinase. Biochim Biophys Acta (1971) 0.77
Normalisation of red blood cell pyruvate kinase in pyruvate kinase deficiency by riboflavin treatment. Clin Chim Acta (1975) 0.77
Membrane characteristics and osmotic fragility of red cells, fractionated with anglehead centrifugation and counterflow centrifugation. Br J Haematol (1985) 0.77
Hydrops fetalis associated with red cell pyruvate kinase deficiency. Genet Couns (1990) 0.76
Isoenzymes of creatine kinase in extracts of various parts and regions of the human central nervous system. Clin Chem (1980) 0.76
A new case of purine nucleoside phosphorylase deficiency: enzymologic, clinical, and immunologic characteristics. Pediatr Res (1987) 0.76
Diagnosis of pyruvate kinase deficiency in a transfusion-dependent patient with severe hemolytic anemia. Am J Hematol (1990) 0.76
Effects of calcium ions on pyruvate kinase from human erythrocytes. Biochimie (1975) 0.76
Vacuoles in red cells from splenectomized subjects originate during cell life: association with glycosylated haemoglobin? Eur J Haematol (1988) 0.76
Urinary purines in a patient with a severely defective T cell immunity and a purine nucleoside phosphorylase deficiency. Adv Exp Med Biol (1977) 0.75
Human erythrocyte hexokinase deficiency. Characterization of a mutant enzyme with abnormal regulatory properties. J Clin Invest (1978) 0.75
Phosphofructokinase and pyruvate kinase in mouse embryonal carcinoma P19 cells in relation to growth and differentiation. Differentiation (1990) 0.75
Metachromatic leukodystrophy and age: a comparative study of clinical, enzymological and ultrastructural findings. Clin Neurol Neurosurg (1979) 0.75
[Value and limitations of the study of gamma-enolase in cerebrospinal fluid as evidence of neuronal degeneration]. Rev Neurol (Paris) (1988) 0.75
Hexokinase, phosphofructokinase and pyruvate kinase isoenzymes in lymphocyte subpopulations. Clin Chim Acta (1984) 0.75